rss
Br J Ophthalmol 84:1387-1391 doi:10.1136/bjo.84.12.1387
  • Original Article
    • Clinical science

Superselective ophthalmic artery fibrinolytic therapy for the treatment of central retinal vein occlusion

Table 1

Clinical characteristics of 26 patients with central retinal vein occlusion before fibrinolysis treatment

Case Age Sex Glaucoma/ IOP
>21 mm Hg 		Duration of visual loss (days) Initial VA Cause of visual loss VA at day 1 Last VA Rubeosis/ NVG Follow up (months)
1 66 F Yes 0.5 CF IBF 20/40 20/50 — 16
2 53 M — 1 20/400 IBF 20/50 20/20 — 6
3 45 M — 0.5 CF IBF 20/20 20/20 — 5
4 67 M Yes 2 20/160 IBF 20/100 20/50 — 4
5 59 M — 11 CF IBF CF CF Rubeosis 28
6 44 M — 2 CF IBF CF CF — 3
7 58 F — 0.5 CF IBF CF 20/200 — 3
8 51 M — 2 CF IBF CF 20/200 — 3
9 56 F Yes 0.5 CF IBF LP LP — 6
10 42 M — 30 20/50 MO 20/25 20/200 — 22
11 69 M — 2 CF MO CF CF Rubeosis 15
12 45 F — 4 CF MO 20/200 20/20 — 14
13 85 M — 3 CF MO HM HM — 2
14 65 M — 5 20/100 MO 20/100 20/200 — 7
15 75 F — 120 CF MO CF 20/400 — 32
16 58 M — 210 20/50 MO 20/50 20/60 — 53
17 61 M Yes 30 20/50 MO 20/40 CF — 18
18 56 M — 60 20/100 MO 20/100 20/100 — 71
19 57 M Yes 90 20/50 MO 20/50 20/400 NVG 31
20 65 M — 60 20/400 MO 20/400 20/400 4
21 69 F Yes 5 20/50 MO 20/40 20/25 6
22 52 M — 1 20/60 CR 20/25 20/25 34
23 73 M Yes 18 20/25 CR 20/40 20/20 32
24 60 M — 7 20/160 CR 20/160 20/200 4
25 50 M Yes 2 CF SMH CF HM Rubeosis 3
26 73 F — 15 CF Ischaemia HM HM NVG 32

  • NVG = neovascular glaucoma; IBF = impairment of retinal blood flow; MO = macular oedema; CR = cilioretinal artery occlusion; SMH = submacular haemorrhage.

This Article

  1. Abstract
  2. Full text
  3. PDF

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.